ATH 13.7% 4.4¢ alterity therapeutics limited


  1. 1,385 Posts.
    lightbulb Created with Sketch. 55
    Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo
    Zhang, JW; Liu, JX; Hou, HM; Chen, DB; Feng, L; Wu, C; Wei, LT; Li, XH
    Wilson disease is an inherited disorder of excessive copper accumulation. The commonly used drug D-penicillamine (PA) or trientine both cause a high incidence (10-50%) of neurological worsening, which rarely occurs with tetrathiomolybdate (TM) treatment. To investigate the mechanisms of neurologic deterioration after the initiation of chelation therapy, brain hydroxyl radical and free copper were assessed in vivo in this study. On days 3, 7, 14, and 21 after PA or TM administration, striatal hydroxyl radical levels of both TX mice and controls were assessed by terephthalic acid (TA) combined with microdialysis and high-performance liquid chromatography (HPLC). Within the same microdialysis samples, free copper was measured by inductively coupled plasma mass spectrometry (ICP-MS). The results showed that both hydroxyl radical and free copper markedly increased in the striatum of TX mice during PA administration but were not elevated when administering TM. These results suggested that the further increased free copper in the brain and oxidative stress caused by some chelators might contribute to the neurological deterioration.

    Copyright © 2015. Published by Elsevier Inc.

    Type: Journal article
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Mkt cap ! $37.87M
Open High Low Value Volume
4.6¢ 4.6¢ 4.4¢ $10.3K 225K

Buyers (Bids)

No. Vol. Price($)
1 15000 4.4¢

Sellers (Offers)

Price($) Vol. No.
5.1¢ 120020 2
View Market Depth
Last update - 15.58pm 19/04/2019 (20 minute delay) ?
ATH (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.